Through a CRISPR dropout screen on murine Cas9 hematopoietic stem and progenitor cells (HSPCs) with enforced expression of MLL-AF9 and Flt3 internal tandem duplication (ITD), METTL3 was identified to be required for the growth of AML cells. Here, KMT2A is linked to acute myeloid leukemia.